Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhancing the Antidepressant Effect of Sleep Deprivation With Modafinil
2005-003196-21Phase 2Terminated
- Sponsor
- Technical University of Munich
- Start
- Apr 2006
- Modality
- Vaccines & Immunotherapeutics, Cell Therapies, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of gemogenovatucel-T in major depressive disorder (MDD) (2 arms), sponsored by Technical University of Munich. Started Apr 2006; status: terminated.
02
Drugs
gemogenovatucel-T
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2005-003196-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003196-21.